Solomon Dhandu

Solomon Dhandu is an accomplished professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as a Director at AstraZeneca since February 2019, Solomon specializes in late-stage oncology biologics development, BLA submission preparation, and managing cross-functional teams. Prior roles include Senior Biologics Project Manager and Biologics Project Manager at MedImmune, where Solomon focused on personalized biologics development, commercialization, and novel oncology drug development. Solomon's career began at Trevigen, Inc., where roles included Production Manager and QC Manager, overseeing project management and quality assurance processes. Solomon holds an MBA in Business Administration from the University of Maryland Global Campus, a Master of Science in Animal Nutrition from the University of Maryland, a Bachelor of Veterinary Science and Animal Husbandry from ANGR Agricultural University, and a Bachelor of Science in Genetics from Nizam College.